Kathy Cao serves as the Associate Director of Finance and Communications for the Gene Editing Institute. In this role, Kathy leads the financial operation and external affairs, strengthening the institute’s financial systems and enhancing its communications and public relations efforts.
Prior to joining the institute, Kathy was a senior Financial Analyst with ChristianaCare’s corporate finance team. In this role, Kathy was responsible for building multibillion-dollar operating budgets across the health system, as well as sophisticated financial modeling systems, including 5-year forecasting, cash forecasting, profitability analyses, and reporting packets and dashboards. Beyond ChristianaCare, Kathy has a background in biomedical engineering, giving her a unique skillset that combines finance and research.
Kathy holds an MBA in Healthcare Management and Financial Management from Johns Hopkins University, an MS in Accounting from the University of Delaware, and a Bachelor of Engineering in Biological Engineering from Jimei University.
